Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

6.63
+0.58009.59%
Post-market: 6.640.0100+0.15%19:51 EDT
Volume:915.57K
Turnover:5.92M
Market Cap:359.86M
PE:-2.70
High:6.67
Open:6.17
Low:6.16
Close:6.05
Loading ...
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2024

Major Issues Report

Form 8-K - Current report
May 01, 2024

Major Issues Report

Form 8-K - Current report
Apr 30, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2024

Major Issues Report

Form 8-K - Current report
Feb 21, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 11, 2024

Major Issues Report

Form 8-K - Current report
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Dec 12, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 11, 2023

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 24, 2023

Major Issues Report

Form 8-K - Current report